Non-Alcoholic Fatty Liver Disease (NAFLD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Non Alcoholic Fatty Liver Pipeline Drugs Analysis
Non-alcoholic fatty liver disease (NAFLD) is a spectrum of disease characterized by hepatic steatosis when no other causes for secondary hepatic fat accumulation (such as excessive alcohol consumption) can be identified. NAFLD ranges from the more benign condition of non-alcoholic fatty liver (NAFL) to nonalcoholic steatohepatitis (NASH), which is at the more severe end of the spectrum.
The NAFLD marketed and pipeline drugs market research report provides a data-driven overview of the current and future competitive landscape in NAFLD therapeutics. This report includes an assessment of the disease epidemiology, leading marketed products with sales forecast, pricing and reimbursement, late-stage pipeline products with phase transition success rate (PTSR), and the likelihood of approval (LoA) for NAFLD.
Leading Marketed Drugs for NAFLD
The leading marketed drug for NAFLD is Saroglitazar. Since there are no FDA-approved treatments currently available, recent guidelines recommend lifestyle interventions, bariatric surgery, and pharmacotherapy as the treatment.
NAFLD Marketed Drugs Segmentation by Routes of Administration
The key route of administration for NAFLD marketed drugs is oral.
NAFLD Marketed Drugs Segmentation by Molecule Type
Most of the marketed drugs for NAFLD are small molecules.
For more molecule type insights into the NAFLD marketed drugs, download a free report sample
Leading Pipeline Drugs for NAFLD
Some of the leading pipeline drugs of NAFLD are resmetirom, oltipraz, secukinumab, aramchol, firsocostat, namodenoson, cilofexor, tropifexor, pegozafermin, ervogastat, ION-224, and others.
NAFLD Pipeline Drugs Segmentation by Mechanism of Action
Some of the key mechanisms of action for NAFLD pipeline drugs are receptor agonist, enzyme inhibitor, receptor antagonist, enzyme activator, biological factor inhibitor, protein and peptide inhibitor, protein and peptide activator, biological factor activator, transporter inhibitor, toxin inhibitor, transporter activator, antigen inhibitor, and enzyme replacement. Receptor agonist is the leading MoA in the pipeline.
NAFLD Pipeline Drugs Analysis, by Mechanisms of Action
For more MoA insights into the NAFLD pipeline drugs market, download a free report sample
NAFLD Pipeline Drugs Segmentation by Routes of Administration
The key routes of administration for NAFLD pipeline drugs are oral, injection, topical, and suppository. Oral is the most preferred route.
NAFLD Pipeline Drugs Analysis, by Routes of Administration
For more routes of administration insights on NAFLD pipeline drugs market, download a free report sample
NAFLD Pipeline Drugs Segmentation by Molecule Type
The NAFLD pipeline comprises mostly small molecules. Biologics and oligonucleotide are the other significant molecule types in the pipeline drugs for NAFLD.
NAFLD Pipeline Drugs Analysis, by Molecule Types
For more molecule type insights into the NAFLD pipeline drugs market, download a free report sample
Top Sponsors in the NAFLD Marketed and Pipeline Drugs Market
Some of the top sponsors in the NAFLD marketed and pipeline drugs market are Pfizer, Gilead Sciences, Novartis, and Madrigal Pharma, Zydus Lifesciences, Hanmi Pharmaceuticals, Merck & Co, MediciNova, and others.
NAFLD Marketed Drugs Report Overview
Key Routes of Administration | Oral |
Key Molecule Types | Small Molecule |
NAFLD Pipeline Drugs Market Report Overview
Key Mechanisms of Action | Receptor Agonist, Enzyme Inhibitor, Receptor Antagonist, Enzyme Activator, Biological Factor Inhibitor, Protein and Peptide Inhibitor, Protein and Peptide Activator, Biological Factor Activator, Transporter Inhibitor, Toxin Inhibitor, Transporter Activator, Antigen Inhibitor, and Enzyme Replacement |
Key Routes of Administration | Oral, Injection, Topical, And Suppository |
Key Molecule Types | Small Molecule, Biologic, and Oligonucleotide |
Top Sponsors (Marketed and
Pipeline Drugs) |
Pfizer, Gilead Sciences, Novartis, and Madrigal Pharma, Zydus Lifesciences, Hanmi Pharmaceuticals, Merck & Co, MediciNova, and others |
Scope
GlobalData’s NAFLD Marketed and Pipeline Drugs Assessment, Clinical Trials, and Competitive Landscape combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the disease marketplace.
Components of the report include:
- Disease Landscape
- Disease Overview
- Epidemiology Overview
- Treatment Overview
- Marketed Products Assessment
- Breakdown by Mechanism of Action, Molecule Type, Route of Administration
- Product Profiles with Sales Forecast
- Pricing and Reimbursement Assessment
- Retail or Manufacturer Price of Products
- Time to Pricing and Time to Reimbursement
- Pipeline Assessment
- Breakdown by Development Stage, Mechanism of Action, Molecule Type, Route of Administration
- Product Profiles with Sales Forecast
- Late-to-mid-stage Pipeline Drugs
- Phase Transition Success Rate and Likelihood of Approval
- Clinical Trials Assessment
- Breakdown of Trials by Phase, Status, Virtual Components, Sponsors, Geography, and Endpoint Status
- Enrolment Analytics, Site Analytics, Feasibility Analysis
- Deals Landscape
- Mergers, Acquisitions, and Strategic Alliances by Region
- Overview of Recent Deals
- Commercial Assessment
- Key Market Players
- Future Market Catalysts
Reasons to Buy
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the NAFLD market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global NAFLD market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Table of Contents
Frequently asked questions
-
What is the key route of administration for NAFLD marketed drugs?
The key route of administration for NAFLD marketed drugs is oral.
-
What is the key molecule type for NAFLD marketed drugs?
The key molecule type for NAFLD marketed drugs is small molecule.
-
What are the key mechanisms of action for NAFLD pipeline drugs?
The key mechanisms of action in the NAFLD pipeline drugs market are receptor agonist, enzyme inhibitor, receptor antagonist, enzyme activator, biological factor inhibitor, protein and peptide inhibitor, protein and peptide activator, biological factor activator, transporter inhibitor, toxin inhibitor, transporter activator, antigen inhibitor, and enzyme replacement.
-
What are the key routes of administration for NAFLD pipeline drugs?
The key routes of administration in the NAFLD pipeline drugs market are oral, injection, topical, and suppository.
-
What are the key molecule types for NAFLD pipeline drugs?
The key molecule types in the NAFLD pipeline drugs market are small molecule, biologic, and oligonucleotide.
-
Who are the top sponsors for the NAFLD marketed and pipeline drugs market?
Some of the top sponsors for the NAFLD marketed and pipeline drugs market are Pfizer, Gilead Sciences, Novartis, and Madrigal Pharma, Zydus Lifesciences, Hanmi Pharmaceuticals, Merck & Co, MediciNova, and others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.